PHOENIX, March 2, 2020 /PRNewswire/ — This week LifePatent, Inc. features its unique LPX product line to the public at Natural Products Expo West. The world’s largest trade show featuring organic and natural health and wellness products will run March 3 through March 7 in Anaheim, California.

LifePatent’s innovative LPX Technology delivers unrivaled bioavailability to the hemp-CBD marketplace. LifePatent Revive is a 15mg THC-Free broad-spectrum capsule. LifePatent Sleep delivers 15mg of full-spectrum whole-hemp cannabinoids and is formulated for those seeking CBD as a sleep aid. LifePatent capsule formulations enable a more convenient, efficient and palatable oral delivery of cannabinoids.

Utilizing its unique patent-pending LPX enhancement technology, the LPX product line delivers unrivaled bioavailability to the hemp-CBD marketplace. Unlike tinctures that rely on sublingual delivery, the capsule formulation enables a more convenient, efficient and palatable oral delivery of cannabinoids to a universal audience.

$69.95.

Annie Rouse, LifePatent’s Chief Knowledge Officer. “For those seeking all of the benefits and results of CBD without the concerns of THC, this product checks all of the boxes.”

$64.95.

Keith Butler, LifePatent’s co-founder and Chief Innovations Officer. “We are thrilled to offer these exciting new LifePatent products that showcase our exclusive absorption technology.”

Phil Vail, LifePatent’s co-founder and Chief Operating Officer.  “In the rapidly expanding market for CBD products, consumers are looking for products that stand apart from the rest. Whether it’s our quality, consistency, purity or innovation, LifePatent products define the industry standard.”

LifePatent.com.

LifePatent is an innovative research company focused on unlocking the natural medicinal properties of hemp. Visit us at LifePatent.com (PRNewsfoto/LifePatent, Inc.)

Cision

http://www.prnewswire.com/news-releases/lifepatent-inc-innovative-lpx-capsules-highlighted-at-natural-products-expo-west-301014045.html

SOURCE LifePatent, Inc.